You have 9 free searches left this month | for more free features.

dopamine agonists

Showing 1 - 25 of 1,399

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Parkinson Disease Trial in Nashville (Pramipexole, Placebo)

Recruiting
  • Parkinson Disease
  • Nashville, Tennessee
    Vanderbilt University Medical Center
May 2, 2022

Problem Gambling Among Young First-episode Psychosis

Recruiting
  • Gambling Disorder
  • Psychotic Disorders
  • Dopamine partial agonists
  • +5 more
  • Montreal, Quebec, Canada
  • +1 more
Jan 16, 2023

Impulse Control Disorder Trial in Korea, Republic of (Levodopa/Carbidopa(200mg/50mg), Dopaminergic Agonists)

Completed
  • Impulse Control Disorder
  • Anyang, Korea, Republic of
  • +4 more
Mar 9, 2021

Prolactinoma, Prolactin-Producing Pituitary Tumor Trial in Amsterdam-Zuidoost, Delft, Leiden (Endoscopic trans-sphenoidal

Recruiting
  • Prolactinoma
  • Prolactin-Producing Pituitary Tumor
  • Endoscopic trans-sphenoidal adenoma resection
  • Dopamine Agonists
  • Amsterdam-Zuidoost, Noord-Holland, Netherlands
  • +2 more
Jul 17, 2020

Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

Enrolling by invitation
  • Parkinson Disease
  • Treatment Adherence
  • Ankara, Turkey
    Ankara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023

Pituitary Tumors, Adenoma Trial in Oslo, Trondheim, Gøteborg (cabergoline)

Recruiting
  • Pituitary Neoplasms
  • Adenoma
  • Oslo, Norway
  • +2 more
Jan 19, 2023

Chronic Anergic-anhedonic Depression Open Trial

Recruiting
  • Depressive Disorder, Treatment-Resistant
    • Strasbourg, France
      CENTRE DE NEUROMODULATION NON INVASIVE DE STRASBOURG (CEMNIS) -
    Oct 25, 2023

    Parkinson Disease Trial in Lund, Cambridge (STEM-PD)

    Recruiting
    • Parkinson Disease
    • STEM-PD
    • Lund, Sweden
    • +1 more
    Dec 7, 2022

    Idiopathic Parkinson's Disease Trial in Pozzilli (PD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF,

    Recruiting
    • Idiopathic Parkinson's Disease
    • PD patients H&Y=1.5-2 Medications ON
    • +4 more
    • Pozzilli, Isernia, Italy
      IRCSS Neuromed Hospital
    May 18, 2022

    Vigor and the LDR in Parkinson Disease

    Recruiting
    • Parkinson Disease
    • carbidopa/levodopa, as prescribed by treating physician
    • Ann Arbor, Michigan
      University of Michigan
    Dec 1, 2022

    Clinical Features Associated With Restless Legs Syndrome.

    Recruiting
    • Restless Legs Syndrome
      • Montpellier, France
        Uhmontpellier
      Sep 18, 2021

      P2X7 Receptor, Inflammation and Neurodegenerative Diseases

      Completed
      • Neuro-Degenerative Disease
      • Memantine, Dopamine receptor-agonists
      • Pisa, Italy
        University of Pisa
      Aug 10, 2019

      Restless Legs Syndrome Trial in Bordeaux (other, behavioral, device)

      Not yet recruiting
      • Restless Legs Syndrome
      • Clinical assessment
      • +3 more
      • Bordeaux, France
        CHU de Bordeaux - Neurophysiologie Clinique de l'Enfant et de l'
      Jan 13, 2023

      Traumatic Brain Injury Trial in Albuquerque (Repetitive Transcranial Magnetic Stimulation)

      Recruiting
      • Traumatic Brain Injury
      • Repetitive Transcranial Magnetic Stimulation
      • Albuquerque, New Mexico
        University of New Mexico Domenici Hall
      Jul 29, 2022

      Motivation, Memory, Self-regulation Trial (Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback)

      Not yet recruiting
      • Motivation
      • +2 more
      • Ventral tegmental area of dopaminergic midbrain (VTA) fMRI neurofeedback
      • (no location specified)
      Jun 26, 2023

      DTx Algorithms for Personalized Parkinson's Disease Treatment

      Not yet recruiting
      • Parkinson Disease
      • Smartwatch Garmin Vivosmart [wearable sensor]
      • +2 more
      • Roma, Italy
      • +2 more
      Jun 13, 2023

      Parkinson Disease Trial in Bern, Geneva (Dopaminergic OFF-drug state, Dopaminergic ON-drug state)

      Recruiting
      • Parkinson Disease
      • Dopaminergic OFF-drug state
      • Dopaminergic ON-drug state
      • Bern, Switzerland
      • +3 more
      Jan 11, 2023

      Hyperprolactinemia, Prolactinoma Trial in New York (Ropinirole)

      Completed
      • Hyperprolactinemia
      • Prolactinoma
      • New York, New York
        Columbia University Medical Center
      Jul 9, 2021

      in Vitro Fertilization, Poor Responder Trial in Toronto (metoclopramide)

      Withdrawn
      • in Vitro Fertilization
      • Poor Responder
      • Toronto, Ontario, Canada
        Mount Sinai Hospital
      Apr 7, 2022

      Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)

      Active, not recruiting
      • Lactation Suppressed
      • Cabergoline 1 MG
      • Placebo
      • Stanford, California
        Stanford University
      Jul 7, 2022

      Parkinson Disease, Memory Impairment Trial in Beijing (Madopar monotherapy, senfrol monotherapy, monotherapy)

      Recruiting
      • Parkinson Disease
      • Memory Impairment
      • Madopar monotherapy
      • +2 more
      • Beijing, China
        Peking University Third Hospital
      Jul 8, 2021

      Parkinson Trial in Boston (Surface EMG, MRI and PET Scan, Surface EMG)

      Terminated
      • Parkinson
      • Surface EMG, MRI and PET Scan
      • Surface EMG
      • Boston, Massachusetts
        Spaulding Rehabilitation Hospital
      Sep 27, 2021

      Sensorimotor Integration in Monogenic Parkinson-dystonia

      Recruiting
      • Parkinson
      • +5 more
      • Transcranial magnetic stimulation (TMS)
      • +3 more
      • Lübeck, Schleswig-Holstein, Germany
        Institute of Systems Motor Science Lübeck
      Jan 27, 2023

      Parkinson Disease Trial in France (Apomorphine, Dopaminergic Agonist + Apomorphine)

      Recruiting
      • Parkinson Disease
      • Marseille, France
      • +6 more
      Jul 2, 2021

      Parkinson Disease Trial in Prague, Bern (Dopaminergic OFF drug state, DBS OFF state, Dopaminergic ON drug state)

      Recruiting
      • Parkinson Disease
      • Dopaminergic OFF drug state
      • +3 more
      • Prague, Czechia
      • +1 more
      Feb 28, 2023